Eliaz Therapeutics Inc. — Form C-U (Regulation Crowdfunding)
Eliaz Therapeutics Inc. of SANTA ROSA, CA filed a Form C-U (Regulation Crowdfunding) with the SEC on 2026-07-07. Target raise $10K, up to $3.0M. Offered through DEALMAKER SECURITIES LLC.
Offering
- Filed: 2026-07-07
- Form: C-U
- Accession: 0001872856-26-000237
- Target amount: $10K
- Maximum amount: $3.0M
- Security type: Other
- Securities offered: 1,747
- Price: $5.5600
- Deadline: 2027-04-15
- Funding portal / intermediary: DEALMAKER SECURITIES LLC
- Intermediary file number: 008-70756
- Intermediary CRD: 000315324
Issuer
- CIK: 0002042609
- Website: https://www.eliaztherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2015-09-17
- Address: 398 TESCONI COURT, SANTA ROSA, CA, 95401
- Employees: 2
Financials (as filed)
- Total assets (most recent): $2.6M
- Cash (most recent): $1.8M
- Revenue (most recent): $332K
- Revenue (prior): $302K
- Net income (most recent): $-1.7M
- Net income (prior): $-955K
- Short-term debt: $1.8M
- Long-term debt: $8.0M
People (6)
| Name | Role | Location |
|---|
| Isaac Eliaz | CEO | Santa Rosa, CA |
| Milton Goss | CFO | Santa Rosa, CA |
| Milton Goss | Chief Financial Officer | Santa Rosa, CA |
| Anat Stern | COO and Head of Business Development | Santa Rosa, CA |
| Dr. Isaac Eliaz | CEO, Director, Founder | Santa Rosa, CA |
| Dr. Isaac Eliaz (Md) | CEO | Santa Rosa, CA |
Reg CF filing history (14)
More